Variable | Non-diabetic controls N = 100 | Type 1 diabetes subjects N = 300 | ||
---|---|---|---|---|
 | Boys (n = 47) | Girls (n = 53) | Boys (n = 152) | Girls (n = 148) |
Age, years1 | 14.9 ± 2.1 | 15.8 ± 2.0 | 15.6 ± 2.1 | 15.2 ± 2.1 |
Race-ethnicity, % NHW3 | 66Â % | 72Â % | 80Â % | 80Â % |
Type 1 diabetes duration, years | -- | -- | 8.9 ± 2.9 | 8.6 ± 3.1 |
Current smoker, %2 | 2Â % | 9Â % | 11Â % | 3Â % |
Tanner stage, %1,2 | Â | Â | Â | Â |
 I | 6 % | 2 % | 5 % | 1 % |
 II | 17 % | 2 % | 12 % | 3 % |
 III | 9 % | 20 % | 10 % | 10 % |
 IV | 34 % | 21 % | 20 % | 35 % |
 V | 34 % | 55 % | 53 % | 51 % |
A1c, %2,3,4 | 5.3 ± 0.3 | 5.3 ± 0.3 | 8.7 ± 1.5 | 9.2 ± 1.7 |
Centered A1c2 | 0.0 ± 0.3 | 0.0 ± 0.3 | -0.3 ± 1.5 | 0.2 ± 1.7 |
BMI Z-score2,3,4 | 0.18 ± 1.14 | 0.39 ± 0.94 | 0.46 ± 0.78 | 0.76 ± 0.71 |
Total cholesterol, mg/dl2,4 | 142 ± 27 | 149 ± 29 | 148 ± 29 | 165 ± 36 |
Triglyceridesa, mg/dl | 70(34-163) | 82(43-235) | 74(27-326) | 78(28-394) |
HDL-c, mg/dl1,2,4 | 46 ± 8 | 50 ± 10 | 49 ± 9 | 54 ± 11 |
LDL-c, mg/dl2,4 | 81 ± 23 | 81 ± 23 | 83 ± 22 | 94 ± 29 |
SBP, mmHg1,2,3,4 | 111 ± 9 | 107 ± 8 | 115 ± 9 | 112 ± 8 |
DBP, mmHg2,3,4 | 64 ± 6 | 64 ± 6 | 68 ± 7 | 69 ± 6 |
Hs-CRPa, mg/dl2,4 | 0.31(0.03-5.85) | 0.48(0.02-9.07) | 0.46(0.05-9.2) | 0.91(0.04-22) |